Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Current Assets: 2009-2025

Historic Current Assets for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $684.6 million.

  • Innoviva's Current Assets rose 70.88% to $684.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $684.6 million, marking a year-over-year increase of 70.88%. This contributed to the annual value of $554.3 million for FY2024, which is 61.03% up from last year.
  • Per Innoviva's latest filing, its Current Assets stood at $684.6 million for Q3 2025, which was up 5.03% from $651.8 million recorded in Q2 2025.
  • Innoviva's 5-year Current Assets high stood at $684.6 million for Q3 2025, and its period low was $148.3 million during Q2 2021.
  • Its 3-year average for Current Assets is $437.5 million, with a median of $358.3 million in 2024.
  • In the last 5 years, Innoviva's Current Assets plummeted by 70.36% in 2021 and then soared by 170.02% in 2022.
  • Over the past 5 years, Innoviva's Current Assets (Quarterly) stood at $313.7 million in 2021, then soared by 41.39% to $443.5 million in 2022, then dropped by 22.39% to $344.2 million in 2023, then surged by 61.03% to $554.3 million in 2024, then spiked by 70.88% to $684.6 million in 2025.
  • Its Current Assets was $684.6 million in Q3 2025, compared to $651.8 million in Q2 2025 and $582.0 million in Q1 2025.